参考文献/References:
［1］BRIDGES JF, JONES C. Patient-based health technology assessment: a vision of the future ［J］. Int J Technol Assess Health Care, 2007, 23(1): 30-35.［2］MENON D, STAFINSKI T. Health technology assessment in Canada: 20 years strong? ［J］. Value Health, 2009, 12(Suppl 2): 14-19.［3］VERONIKI AA, TRICCO AC, WATT J, et al. Rapid antigen-based and rapid molecular tests for the detection of SARS-CoV-2: a rapid review with network meta-analysis of diagnostic test accuracy studies ［J］. BMC Med, 2023, 21(1): 110.［4］AMANI B, AMANI B. Efficacy and safety of nirmatrelvir/ritonavir (Paxlovid) for COVID-19: a rapid review and meta-analysis ［J］. J Med Virol, 2023, 95(2): e28441.［5］NEMZOFF C, SHAH HA, HEUPINK LF, et al. Adaptive health technology assessment: a scoping review of methods ［J］. Value Health, 2023, 26(10): 1549-1557.［6］SPECKEMEIER C, NIEMANN A, WASEM J, et al. Methodological guidance for rapid reviews in healthcare: a scoping review ［J］. Res Synth Methods, 2022, 13(4): 394-404.［7］KALTENTHALER E, COOPER K, PANDOR A, et al. The use of rapid review methods in health technology assessments: 3 case studies ［J］. BMC Med Res Methodol, 2016, 16(1): 108.［8］吴 雪, 景城阳, 施兰君, 等. 国内外卫生技术评估方法指南的系统评价［J］.中国循证医学杂志, 2024, 24(9): 1021-1029.［9］吴亚楠. 快速卫生技术评估报告规范研究［D］.兰州：兰州大学, 2024.［10］李幼平, 喻佳洁, 孙 鑫. 快速评估方法与流程的探索［J］.中国循证医学杂志, 2014, 14(5): 497-500.［11］唐惠林, 门 鹏, 翟所迪. 药物快速卫生技术评估方法及应用［J］.临床药物治疗杂志, 2016, 14(2): 1-4.［12］VARLEY , TILSON L, FOGARTY E, et al. The utility of a rapid review evaluation process to a national HTA agency ［J］. Pharmacoeconomics, 2022, 40(2): 203-214.［13］WATT A, CAMERON A, STURM L, et al. Rapid reviews versus full systematic reviews: an inventory of current methods and practice in health technology assessment ［J］. Int J Technol Assess Health Care, 2008, 24(2): 133-139.［14］MCCULLAGH L, BARRY M. The pharmacoeconomic evaluation process in Ireland［J］. Pharmacoeconomics, 2016, 34(12): 1267-1276.［15］李苗苗, 吴 雪, 徐思敏, 等. 快速卫生技术评估的概况性综述［J］. 中国中药杂志, 2022, 47(12): 3125-3135.［16］孟佳佳, 王陈萍, 王丹丹, 等. 艾多沙班治疗癌症相关静脉血栓栓塞症的快速卫生技术评估［J］. 中国药业, 2024, 33(17): 122-126.［17］许金秋, 沈 凯. 阿帕替尼治疗晚期非小细胞肺癌的快速卫生技术评估［J］.中国合理用药探索, 2022, 19(6): 50-54.［18］霍秀颖, 王 洋, 李 婷, 等. 丙泊酚用于胃肠镜检查的快速卫生技术［J］.中国医院用药评价与分析, 2021, 21(1): 81-84,89.［19］佟玉顺, 智 硕. 丙泊酚加阿片类镇痛药在无痛胃肠镜中的麻醉效果分析［J］.医药前沿, 2024, 14(4): 12-14.［20］黄晶晶, 李 昊, 郑晓春. 2%利多卡因与依托咪酯复合丙泊酚用于老年胃镜检查的比较分析［J］.福建医药杂志, 2022, 44(2): 24-27.［21］周星宇, 杨 毅, 魏 艳, 等. PET/MR诊断癌症安全性、有效性和经济性文献研究：基于快速卫生技术评估分析［J］.中国医院管理, 2021, 41(9): 29-33.［22］喻佳洁, 王应强, 李幼平, 等. 达·芬奇手术系统安全性和有效性的快速评估［J］.中国循证医学杂志, 2014, 14(5): 530-540.［23］樊志磊, 杨 毅, 张 晨, 等. 内窥镜手术器械控制系统的快速卫生技术评估：以前列腺癌根治术为例［J］. 中国医院管理, 2021, 41(9): 24-28.［24］杨宗霞, 沈建通, 李幼平, 等. 螺旋断层放疗系统治疗肿瘤的快速卫生技术评估［J］.中国循证医学杂志, 2014, 14(9): 1052-1069.［25］胡紫馨, 谢金平, 王苑如, 等. CAR-T疗法治疗B细胞血液恶性肿瘤的快速卫生技术评估［J］.中国药房, 2021, 32(23): 2895-2900.［26］VISNANSKY M, MESAROS S. PMD75 patient self-testing of oral anticoagulation therapy by CoaguChek XS system. Rapid health technology assessment in slovak health care environment ［J］. Value in Health, 2011, 14(7): 257-258.［27］CARDWELL K, JORDAN K, BYRNE P, et al. The effectiveness of non-contact thermal screening as a means of identifying cases of Covid-19: a rapid review of the evidence ［J］. Rev Med Virol, 2021, 31(4): e2192.［28］COMBER L, WALSH KA, JORDAN K, et al. Alternative clinical specimens for the detection of SARS-CoV-2: a rapid review ［J］. Rev Med Virol, 2021, 31(4): e2185.［29］唐 密, 杨 海, 耿劲松, 等. 我国医院卫生技术评估通用要求研究［J］.中国卫生质量管理, 2024, 31(12): 7-11.［30］徐思敏, 赵 晖, 胡 晶, 等. 中医医院开展卫生技术评估的现况调研［J］.中国实验方剂学杂志, 2024, 30(4): 190-197.［31］张钟文, 李瑞锋. 加强中医药高层次人才队伍建设推动中医医院高质量发展［J］.中国卫生质量管理, 2023, 30(11): 11-14.［32］吴 雪, 王文雅, 廖 星, 等. 中医药卫生技术评估实施规范的构建与内容介绍［J］.中国中药杂志, 2024, 49(20): 5643-5651.［33］STONE JA. Mobile medicine: digital dynamo or virtual vaporware ［J］. Can J Cardiol, 2017, 33(2): 216-218.［34］VERVOORT D, TAM DY, WIJEYSUNDERA HC. Health technology assessment for cardiovascular digital health technologies and artificial intelligence: why is it different? ［J］. Can J Cardiol, 2022, 38(2): 259-266.